These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Case 266. Cadman CJ; Fraser L; McArthur C Radiology; 2019 Feb; 290(2):566-568. PubMed ID: 30673499 [TBL] [Abstract][Full Text] [Related]
9. Solid bone tumors of the spine: Diagnostic performance of apparent diffusion coefficient measured using diffusion-weighted MRI using histology as a reference standard. Pozzi G; Albano D; Messina C; Angileri SA; Al-Mnayyis A; Galbusera F; Luzzati A; Perrucchini G; Scotto G; Parafioriti A; Zerbi A; Sconfienza LM J Magn Reson Imaging; 2018 Apr; 47(4):1034-1042. PubMed ID: 28755383 [TBL] [Abstract][Full Text] [Related]
10. Case 265: Lemmel Syndrome or Biliary Obstruction Due to a Periampullary Duodenal Diverticulum. Venkatanarasimha N; Yong YR; Gogna A; Tan BS Radiology; 2019 May; 291(2):542-545. PubMed ID: 30998446 [TBL] [Abstract][Full Text] [Related]
11. Periarticular bone findings in rheumatoid arthritis: T2-weighted versus contrast-enhanced T1-weighted MRI. Yao L; Magalnick M; Wilson M; Lipsky P; Goldbach-Mansky R AJR Am J Roentgenol; 2006 Aug; 187(2):358-63. PubMed ID: 16861538 [TBL] [Abstract][Full Text] [Related]
12. T2-weighted MR imaging of the upper part of the abdomen: should fat suppression be used routinely? Lu DS; Saini S; Hahn PF; Goldberg M; Lee MJ; Weissleder R; Gerard B; Halpern E; Cats A AJR Am J Roentgenol; 1994 May; 162(5):1095-100. PubMed ID: 8165989 [TBL] [Abstract][Full Text] [Related]
13. Case 259. Tian D; Zhu X; Xue R; Zhao P; Yao Y Radiology; 2018 Jul; 288(1):308-311. PubMed ID: 29924717 [TBL] [Abstract][Full Text] [Related]
15. [A comparison of positive and negative enteral contrast media for the magnetic resonance tomography of the abdomen]. Kaminsky S; Laniado M; Gogoll M; Clauss W; Langer M Rofo; 1994 Sep; 161(3):220-5. PubMed ID: 7919247 [TBL] [Abstract][Full Text] [Related]
20. A multicenter, randomized, double-blind study to evaluate the safety, tolerability, and efficacy of OptiMARK (gadoversetamide injection) compared with Magnevist (gadopentetate dimeglumine) in patients with liver pathology: results of a Phase III clinical trial. Rubin DL; Desser TS; Semelka R; Brown J; Nghiem HV; Stevens WR; Bluemke D; Nelson R; Fultz P; Reimer P; Ho V; Kristy RM; Pierro JA J Magn Reson Imaging; 1999 Feb; 9(2):240-50. PubMed ID: 10077020 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]